Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul, 138-736, Korea.
Surg Endosc. 2022 Aug;36(8):5772-5783. doi: 10.1007/s00464-022-09114-z. Epub 2022 Mar 17.
With the recent rapid increase in the prevalence of obesity, the number of obese patients requiring liver resection, including laparoscopy, has increased. Accordingly, evaluating the outcome of laparoscopic liver resection in obese patients is increasingly important. This study aimed to compare the safety and feasibility of laparoscopic major liver resection (LMR) and open major liver resection (OMR) in patients with a high body mass index (BMI > 25.0 kg/m).
We reviewed 521 patients with high BMI (> 25.0 kg/m) who underwent major liver resection for various indications between January 2009 and November 2018 at Asan Medical Center. We performed 1:1 propensity score matching of the LMR and OMR groups, with 120 patients subsequently included in each group.
LMR was associated with lower blood loss and shorter postoperative hospital stays (p < 0.001). Although there was no significant difference in overall complications (p = 0.080), non-liver-specific complications were observed less frequently after LMR (p = 0.025). American Society of Anesthesiologists class > II, BMI > 30 kg/m, and malignancy were independent predictors of morbidity. In a subgroup analysis of patients with hepatocellular carcinoma, there was no significant difference between the two groups in overall survival (hazard ratio 0.225; 95% confidence interval 0.049-1.047; p = 0.057) and recurrence-free survival (hazard ratio 0.761; 95% confidence interval 0.394-1.417; p = 0.417).
Obesity should not be considered a contraindication for major liver resection using a laparoscopic approach; however, when applying this approach for resecting malignancies in patients with a BMI > 30 kg/m and comorbid diseases, special attention should be paid to the possibility of complications.
随着肥胖症患病率的迅速上升,需要进行肝切除术(包括腹腔镜手术)的肥胖患者数量也在增加。因此,评估肥胖患者腹腔镜肝切除术的结果变得越来越重要。本研究旨在比较高体重指数(BMI>25.0 kg/m)患者行腹腔镜肝切除术(LMR)和开腹肝切除术(OMR)的安全性和可行性。
我们回顾了 2009 年 1 月至 2018 年 11 月期间,在 Asan 医疗中心因各种原因接受肝切除术的 521 名高 BMI(>25.0 kg/m)患者的病例资料。我们对 LMR 和 OMR 组进行了 1:1 倾向评分匹配,随后每组各纳入 120 例患者。
LMR 组的出血量和术后住院时间均较短(p<0.001)。尽管两组的总体并发症发生率无显著差异(p=0.080),但 LMR 后非肝脏特异性并发症的发生率较低(p=0.025)。美国麻醉医师协会(ASA)分级>II 级、BMI>30 kg/m 和恶性肿瘤是发病率的独立预测因素。在肝细胞癌患者的亚组分析中,两组的总生存率(风险比 0.225;95%置信区间 0.049-1.047;p=0.057)和无复发生存率(风险比 0.761;95%置信区间 0.394-1.417;p=0.417)均无显著差异。
肥胖不应被视为腹腔镜肝切除术的禁忌证;然而,对于 BMI>30 kg/m 且合并疾病的患者,在应用腹腔镜技术切除恶性肿瘤时,应特别注意并发症的可能性。